ArticleJournal of the National Cancer Institute2022

RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer.

Michael Mark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.